Greg Parsonage

1.9k total citations
17 papers, 1.5k citations indexed

About

Greg Parsonage is a scholar working on Immunology, Oncology and Rheumatology. According to data from OpenAlex, Greg Parsonage has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 6 papers in Oncology and 6 papers in Rheumatology. Recurrent topics in Greg Parsonage's work include Immunotherapy and Immune Responses (5 papers), Cell Adhesion Molecules Research (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Greg Parsonage is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Cell Adhesion Molecules Research (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Greg Parsonage collaborates with scholars based in United Kingdom, Hong Kong and United States. Greg Parsonage's co-authors include Christopher D. Buckley, Mike Salmon, Andrew Filer, David L. Simmons, Janet M. Lord, G. Ed Rainger, Dagmar Scheel‐Toellner, Gerard B. Nash, N. Henriquez and Arne N. Akbar and has published in prestigious journals such as Nature, PLoS ONE and American Journal Of Pathology.

In The Last Decade

Greg Parsonage

17 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Parsonage United Kingdom 14 613 516 404 246 219 17 1.5k
Peter Ruminski United States 16 612 1.0× 595 1.2× 352 0.9× 121 0.5× 298 1.4× 42 2.0k
Daisuke Kurotaki Japan 27 1.1k 1.7× 725 1.4× 322 0.8× 190 0.8× 157 0.7× 51 1.9k
Sabine Krüger‐Krasagakes Germany 20 1.1k 1.7× 453 0.9× 317 0.8× 147 0.6× 338 1.5× 28 1.7k
J. Middleton United Kingdom 11 487 0.8× 325 0.6× 405 1.0× 214 0.9× 304 1.4× 17 1.2k
Omar Perbellini Italy 22 922 1.5× 327 0.6× 427 1.1× 214 0.9× 420 1.9× 50 1.9k
Vera M. Ripoll United Kingdom 14 407 0.7× 486 0.9× 210 0.5× 308 1.3× 77 0.4× 25 1.3k
Gabriella Sármay Hungary 24 1.0k 1.7× 909 1.8× 233 0.6× 595 2.4× 173 0.8× 98 2.2k
Osamu Hosono Japan 23 352 0.6× 491 1.0× 623 1.5× 116 0.5× 144 0.7× 70 1.4k
Shuji Sumitomo Japan 23 804 1.3× 392 0.8× 339 0.8× 399 1.6× 58 0.3× 70 1.7k
Theodore J. Yun United States 15 723 1.2× 1.0k 1.9× 602 1.5× 123 0.5× 148 0.7× 22 1.7k

Countries citing papers authored by Greg Parsonage

Since Specialization
Citations

This map shows the geographic impact of Greg Parsonage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Parsonage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Parsonage more than expected).

Fields of papers citing papers by Greg Parsonage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Parsonage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Parsonage. The network helps show where Greg Parsonage may publish in the future.

Co-authorship network of co-authors of Greg Parsonage

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Parsonage. A scholar is included among the top collaborators of Greg Parsonage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Parsonage. Greg Parsonage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zheng, Yong, Greg Parsonage, Xiaodong Zhuang, et al.. (2015). Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma. Cancer Immunology Research. 3(10). 1138–1147. 28 indexed citations
2.
Filer, Andrew, Philipp Antczak, Greg Parsonage, et al.. (2015). Stromal Transcriptional Profiles Reveal Hierarchies of Anatomical Site, Serum Response and Disease and Identify Disease Specific Pathways. PLoS ONE. 10(3). e0120917–e0120917. 13 indexed citations
3.
Parsonage, Greg, Lee R. Machado, Andrew McLarnon, et al.. (2012). CXCR6 and CCR5 Localize T Lymphocyte Subsets in Nasopharyngeal Carcinoma. American Journal Of Pathology. 180(3). 1215–1222. 36 indexed citations
4.
Parsonage, Greg, Rupesh I. Bhatt, D. Michael A. Wallace, et al.. (2011). T Lymphocyte Recruitment into Renal Cell Carcinoma Tissue: A Role for Chemokine Receptors CXCR3, CXCR6, CCR5, and CCR6. European Urology. 61(2). 385–394. 77 indexed citations
5.
Filer, Andrew, Greg Parsonage, John Fitton, et al.. (2009). Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways. Arthritis & Rheumatism. 60(6). 1604–1614. 135 indexed citations
6.
Chan, Antoni, Andrew Filer, Greg Parsonage, et al.. (2008). Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast‐like synoviocytes and natural killer cells. Arthritis & Rheumatism. 58(3). 707–717. 39 indexed citations
7.
Parsonage, Greg, Andrew Filer, Debbie L. Hardie, et al.. (2008). Prolonged, granulocyte–macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha. Arthritis Research & Therapy. 10(2). R47–R47. 69 indexed citations
8.
Filer, Andrew, Greg Parsonage, Emily Smith, et al.. (2006). Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: Site‐specific versus activation‐dependent survival of T cells and neutrophils. Arthritis & Rheumatism. 54(7). 2096–2108. 80 indexed citations
9.
Hardy, Rowan, Andrew Filer, Mark S. Cooper, et al.. (2006). Differential expression, function and response to inflammatory stimuli of 11β-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation. Arthritis Research & Therapy. 8(4). R108–R108. 80 indexed citations
10.
Parsonage, Greg, Marta A. Toscano, Germán A. Bianco, et al.. (2006). Roles of galectins in chronic inflammatory microenvironments. 1(4). 441–454. 2 indexed citations
11.
Haworth, Oliver, Angela Burman, Greg Parsonage, et al.. (2005). Stromal cells as new therapeutic targets in rheumatoid arthritis. Therapy. 2(1). 121–129. 1 indexed citations
12.
Burman, Angela, Oliver Haworth, Paul F. Bradfield, et al.. (2004). The role of leukocyte-stromal interactions in chronic inflammatory joint disease. Joint Bone Spine. 72(1). 10–16. 17 indexed citations
13.
Parsonage, Greg, Andrew Filer, Oliver Haworth, et al.. (2004). A stromal address code defined by fibroblasts. Trends in Immunology. 26(3). 150–156. 231 indexed citations
14.
Bradfield, Paul F., Andrew Thomas, Angela Burman, et al.. (2004). Rôle des interactions entre cellules stromales et leucocytaires dans les maladies articulaires inflammatoires chroniques. Revue du Rhumatisme. 72(1). 10–16. 1 indexed citations
15.
Filer, Andrew, Ewan A. Ross, Stuart Martin, et al.. (2003). Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns. Thrombosis and Haemostasis. 90(10). 688–697. 180 indexed citations
16.
Bradfield, Paul F., Nicole Amft, Elizabeth Vernon‐Wilson, et al.. (2003). Rheumatoid fibroblast‐like synoviocytes overexpress the chemokine stromal cell–derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis & Rheumatism. 48(9). 2472–2482. 146 indexed citations
17.
Buckley, Christopher D., Darrell Pilling, N. Henriquez, et al.. (1999). RGD peptides induce apoptosis by direct caspase-3 activation. Nature. 397(6719). 534–539. 381 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Ruminski Breakdown of academic impact, for papers by Daisuke Kurotaki Breakdown of academic impact, for papers by Sabine Krüger‐Krasagakes Breakdown of academic impact, for papers by J. Middleton Breakdown of academic impact, for papers by Omar Perbellini Breakdown of academic impact, for papers by Vera M. Ripoll Breakdown of academic impact, for papers by Gabriella Sármay Breakdown of academic impact, for papers by Osamu Hosono Breakdown of academic impact, for papers by Shuji Sumitomo Breakdown of academic impact, for papers by Theodore J. Yun
Rankless by CCL
2026